0001562180-22-003383.txt : 20220413
0001562180-22-003383.hdr.sgml : 20220413
20220413160925
ACCESSION NUMBER: 0001562180-22-003383
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220401
FILED AS OF DATE: 20220413
DATE AS OF CHANGE: 20220413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morrison Briggs
CENTRAL INDEX KEY: 0001654430
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37708
FILM NUMBER: 22824802
MAIL ADDRESS:
STREET 1: C/O SYNDAX PHARMACEUTICALS, INC.
STREET 2: 400 TOTTEN POND ROAD, SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001395937
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320162505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-419-1400
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
4/A
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4/A
2022-04-01
2022-04-05
false
0001395937
Syndax Pharmaceuticals Inc
SNDX
0001654430
Morrison Briggs
C/O SYNDAX PHARMACEUTICALS, INC.
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3
WALTHAM
MA
02451
true
true
false
false
President, Head of R&D
Common Stock
2022-04-01
4
M
false
70545.00
7.20
A
88381.00
D
Common Stock
2022-04-04
4
M
false
3128.00
7.20
A
20964.00
D
Stock Options (Right to buy)
7.20
2022-04-01
4
M
false
70545.00
0.00
D
2025-06-30
Common Stock
70545.00
0.00
D
Stock Options (Right to buy)
7.20
2022-04-04
4
M
false
3128.00
0.00
D
2025-06-30
Common Stock
3128.00
0.00
D
The Reporting Person is not reporting any new transactions in this filing.
Amendment filed to correct previously filed Form that contained an incorrect option exercise price and expiration date.
This option is fully vested.
/s/ Michael A. Metzger, Attorney-in-fact
2022-04-13